Free Trial
OTCMKTS:TRXDW

TransEnterix (TRXDW) Stock Price, News & Analysis

TransEnterix logo
$0.15 0.00 (0.00%)
As of 02/28/2025

About TransEnterix Stock (OTCMKTS:TRXDW)

Key Stats

Today's Range
$0.15
$0.15
50-Day Range
$0.15
$0.15
52-Week Range
$0.12
$0.18
Volume
N/A
Average Volume
8,250 shs
Market Capitalization
$21.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

Receive TRXDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter.

TRXDW Stock News Headlines

Life Science Partners L P Synergy's Net Worth
Asensus Surgical Inc (ASXC)
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
TransEnterix, Inc. (TRXDW)
Surgical Robots Global Market Report 2023
Asensus Surgical (NYSEMKT: ASXC)
See More Headlines

TRXDW Stock Analysis - Frequently Asked Questions

TransEnterix's stock was trading at $0.15 on January 1st, 2025. Since then, TRXDW stock has increased by 0.0% and is now trading at $0.15.
View the best growth stocks for 2025 here
.

TransEnterix, Inc. (OTCMKTS:TRXDW) announced its earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to analyst estimates of $0.73 million. TransEnterix had a negative net margin of 2,149.15% and a negative trailing twelve-month return on equity of 83.74%.

Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/05/2020
Today
3/03/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRXDW
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-154,200,000.00
Net Margins
-2,149.15%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.53 million
Cash Flow
$0.11 per share
Price / Cash Flow
1.40
Book Value
$2.68 per share
Price / Book
0.06

Miscellaneous

Free Float
N/A
Market Cap
$21.42 million
Optionable
Not Optionable
Beta
2.56
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:TRXDW) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners